Clinical Trials and Regulatory Pathways (October 2010 - October 2011)

The report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help deliver better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.